Listeria - Zašto ne možemo ignorisati rizik

Listeria Monocytogenes

Verovatno ste svesni da je Listeria monocitogenes vruća tema u prehrambenoj industriji i medijskim kućama. Listeria, jedna od najsmrtonosnijih patogena u hrani, tradicionalno je vezana za kontaminaciju mesa, proizvoda od mesa i nepasterizovanih sireva. Međutim, u poslednjih nekoliko godina, značajno se povećava broj bolesti izazvanih hranom koje se pripisuju Listeria monocitogenes. 

Ukoliko vas ova tema zanima, možete besplatno da preuzmite vodič o Listeria na sledećem linku...https://aib-international.wishpond.com/landing-page-1459928/

Reference - Analiza veličine čestica za čvrste dozne oblike

1. M.E. Fayed and L. Otten, Handbook of Powder Science & Technology, 2nd, Chapman & Hall, 1997.
2. A. J. Hlinak, K. Kuriyan, K. R. Morris, G. W. Reklaitis, and P. K. Basu. Understanding critical material properties for solid dosage form design. Journal of Pharmaceutical Innovation, vol.1, 2006, pp.12–17.
3. B.Y. Shekunov, P. Chattopadhyay, H.H.Y. Tong, and A.H.L. Chow, Particle Size analysis in Pharmaceutics: Principles, Methods and Applications, Pharmaceutical Research Vol. 24, No.2, 2006, pp.203-227.
4. S.M. Snorek et al., PQRI Recommendation on Particle Size Analysis of Drug Substances Used in Oral Dosage Forms, Journal of Pharmaceutical Science, Vol. 96, No.6, 2007, pp.1451-1467.
5. ICH Guideline Q6A, Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances, 2000.
6. H.A.Lieberman, L. Lachman, and J.B. Schwartz, Pharmaceutical Dosage Forms: Tablets, 2nd, Marcel Dekker, 1989
7. N.A. Armstrong, Tablet Manufacture, Encyclopedia of Pharmaceutical Technology, Marcel Dekker, 2002
8. V. Swaminathan and D.O. Kildsig, Polydisperse powder mixtures: effect of particle size and shape on mixture stability. Drug. Dev. Ind. Pharm., vol. 28, 2002, pp.41-48.
9. C. Sun and D.J. W. Grant, Influence of crystal shape on the tableting performance of i-iysine monohydrochloride dehydrate, Journal of Pharmaceutical Science, vol.90, 2001, pp.569-579.
10. U.S. Food and Drug Administration, Guide to Inspection of Oral Solid Dosage Forms: Pre/Post Approval Issues for Development and Validation, 1994.
11. G. Heinicke, F. Matthews, and J.B. Schwartz, The Effects of Substrate Size, Surface Area, and Density on Coat Thickness of Multi-Particulate Dosage Forms, Pharmaceutical Development and Technology vol.10. 2005, pp.85-96.
12. G. Heinicke and J.B. Schwartz, Assessment of Dynamic Image Analysis as a Surrogate Dissolution Test for a Coated Multiparticulate Product, Pharmaceutical Development and Technology vol.11. 2006, pp.403-408.
13. A. Jillavenkatesa, S.J. Dapkunas, and L.H. Lum, Particle Size Characterization, National Institute of Standards and Technology, Special Publication 960-1, 2001.
14. T. Allen, Particle Size Measurement, 4th, Chapman and Hall, London, 1993.
15. ISO 13320-1, Particle Size analysis-Laser Diffraction methods-Part 1: General Principles, International Organization for Standardization, 1999.
16. The United States Pharmacopeia 30-The National Formulary 25, <1225>, Validation of Compendial Procedure, 2008.
17. R. Bell, A. Dennis, B. Hendriksen, N. Norht, and J. Sherwood, Position Paper on Particle Sizing: Sample preparation, method validation, and data presentation, Pharmaceutical Technology Europe, November 1999, pp.36-42.
18. S.A. Lerke and S.A. Adams, Development and Validation of a Particle Size Distribution Method for Analysis of Drug substance, American Pharmaceutical Review, Fall 2002.